Inhibition of insulin amyloid fibril formation by cyclodextrins

Keisuke KitagawaDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan,

Yohei MisumiDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan,

Mitsuharu UedaDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan,

Yuya HayashiDepartment of Physical Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan,

Masayoshi TasakiDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan,

Konen ObayashiDepartment of Morphological and Physiological Sciences, Graduate School of Health Sciences, Kumamoto University, Kumamoto, Japan, and

Taro YamashitaDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan,

Hirofumi JonoDepartment of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan

Hidetoshi ArimaDepartment of Physical Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan,

Yukio AndoDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan, Correspondence[email protected]

Your download is now in progress and you may close this window